Private Equity
Jeremy Coller, the firm’s founder and chief investment officer, said the bulk of the oversubscribed fund was raised in “about six months”.
2 min read · 05 January 2016
The fund was in market for less than three months and will follow CI Capital’s strategy of investing $25m to $100m in mid-market buyouts in North America.
2 min read · 04 January 2016
<p>John Angelo, who co-founded his eponymous firm with Michael Gordon in 1988, died at 74 after a long battle with cancer.</p> <p> </p>
2 min read · 04 January 2016
Pfm spoke to Silverfleet Capital managing partner <span class="BOLD">Neil MacDougall</span> about how his group tackled AIFMD and other new rules while busting past its $850m hard-cap for Fund II.
3 min read · 04 January 2016
Pfm spoke to Ridgemont Equity Partners partner <span class="BOLD">Travis Hain</span> about how the firm managed to corral $995m for its Fund II in only seven months.
3 min read · 04 January 2016
Pfm spoke to The Carlyle Group’s head of global investor relations <span class="BOLD">Mike Arpey</span> about how firms raising multiple, simultaneous funds approach investor relations.
3 min read · 04 January 2016
It’s a nice problem to have, but managing a fundraising that is the subject of more interest than it can handle is fraught with investor relations challenges for GPs.
7 min read · 04 January 2016
As demand for co-investment opportunities escalates, GPs are considering new ways to manage the process, including ‘chief co-investment officers’, fewer promises during fundraising and whether to raise separate top-up funds.
7 min read · 04 January 2016
John Angelo, the head and co-founder of New York-based investment firm Angelo, Gordon & Co, has died at age 74, according to an email sent to the firm's employees, Reuters News reported.
1 min read · 04 January 2016
OrbiMed’s most recent investment was earlier this month when it participated in a $53 million Series B financing for ORIC Pharmaceuticals.
1 min read · 22 December 2015
